Global Rufinamide Market Growth (Status and Outlook) 2022-2028
- LP 4798511
- 64 Pages
- January 2022
- Pharmaceuticals
The United States Rufinamide market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Rufinamide market, reaching US$ million by the year 2028. As for the Europe Rufinamide landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Rufinamide players cover Eisai, Glenmark Pharms, Mylan, and West-ward Pharms, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Rufinamide market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Tablets
Oral suspension
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Adults
Pediatric patients
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Eisai
Glenmark Pharms
Mylan
West-ward Pharms
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Rufinamide Market Size 2017-2028
2.1.2 Rufinamide Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Rufinamide Segment by Type
2.2.1 Tablets
2.2.2 Oral suspension
2.3 Rufinamide Market Size by Type
2.3.1 Rufinamide Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Rufinamide Market Size Market Share by Type (2017-2022)
2.4 Rufinamide Segment by Application
2.4.1 Adults
2.4.2 Pediatric patients
2.5 Rufinamide Market Size by Application
2.5.1 Rufinamide Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Rufinamide Market Size Market Share by Application (2017-2022)
3 Rufinamide Market Size by Player
3.1 Rufinamide Market Size Market Share by Players
3.1.1 Global Rufinamide Revenue by Players (2020-2022)
3.1.2 Global Rufinamide Revenue Market Share by Players (2020-2022)
3.2 Global Rufinamide Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Rufinamide by Regions
4.1 Rufinamide Market Size by Regions (2017-2022)
4.2 Americas Rufinamide Market Size Growth (2017-2022)
4.3 APAC Rufinamide Market Size Growth (2017-2022)
4.4 Europe Rufinamide Market Size Growth (2017-2022)
4.5 Middle East & Africa Rufinamide Market Size Growth (2017-2022)
5 Americas
5.1 Americas Rufinamide Market Size by Country (2017-2022)
5.2 Americas Rufinamide Market Size by Type (2017-2022)
5.3 Americas Rufinamide Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Rufinamide Market Size by Region (2017-2022)
6.2 APAC Rufinamide Market Size by Type (2017-2022)
6.3 APAC Rufinamide Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Rufinamide by Country (2017-2022)
7.2 Europe Rufinamide Market Size by Type (2017-2022)
7.3 Europe Rufinamide Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Rufinamide by Region (2017-2022)
8.2 Middle East & Africa Rufinamide Market Size by Type (2017-2022)
8.3 Middle East & Africa Rufinamide Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Rufinamide Market Forecast
10.1 Global Rufinamide Forecast by Regions (2023-2028)
10.1.1 Global Rufinamide Forecast by Regions (2023-2028)
10.1.2 Americas Rufinamide Forecast
10.1.3 APAC Rufinamide Forecast
10.1.4 Europe Rufinamide Forecast
10.1.5 Middle East & Africa Rufinamide Forecast
10.2 Americas Rufinamide Forecast by Country (2023-2028)
10.2.1 United States Rufinamide Market Forecast
10.2.2 Canada Rufinamide Market Forecast
10.2.3 Mexico Rufinamide Market Forecast
10.2.4 Brazil Rufinamide Market Forecast
10.3 APAC Rufinamide Forecast by Region (2023-2028)
10.3.1 China Rufinamide Market Forecast
10.3.2 Japan Rufinamide Market Forecast
10.3.3 Korea Rufinamide Market Forecast
10.3.4 Southeast Asia Rufinamide Market Forecast
10.3.5 India Rufinamide Market Forecast
10.3.6 Australia Rufinamide Market Forecast
10.4 Europe Rufinamide Forecast by Country (2023-2028)
10.4.1 Germany Rufinamide Market Forecast
10.4.2 France Rufinamide Market Forecast
10.4.3 UK Rufinamide Market Forecast
10.4.4 Italy Rufinamide Market Forecast
10.4.5 Russia Rufinamide Market Forecast
10.5 Middle East & Africa Rufinamide Forecast by Region (2023-2028)
10.5.1 Egypt Rufinamide Market Forecast
10.5.2 South Africa Rufinamide Market Forecast
10.5.3 Israel Rufinamide Market Forecast
10.5.4 Turkey Rufinamide Market Forecast
10.5.5 GCC Countries Rufinamide Market Forecast
10.6 Global Rufinamide Forecast by Type (2023-2028)
10.7 Global Rufinamide Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Eisai
11.1.1 Eisai Company Information
11.1.2 Eisai Rufinamide Product Offered
11.1.3 Eisai Rufinamide Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Eisai Main Business Overview
11.1.5 Eisai Latest Developments
11.2 Glenmark Pharms
11.2.1 Glenmark Pharms Company Information
11.2.2 Glenmark Pharms Rufinamide Product Offered
11.2.3 Glenmark Pharms Rufinamide Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Glenmark Pharms Main Business Overview
11.2.5 Glenmark Pharms Latest Developments
11.3 Mylan
11.3.1 Mylan Company Information
11.3.2 Mylan Rufinamide Product Offered
11.3.3 Mylan Rufinamide Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Mylan Main Business Overview
11.3.5 Mylan Latest Developments
11.4 West-ward Pharms
11.4.1 West-ward Pharms Company Information
11.4.2 West-ward Pharms Rufinamide Product Offered
11.4.3 West-ward Pharms Rufinamide Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 West-ward Pharms Main Business Overview
11.4.5 West-ward Pharms Latest Developments
12 Research Findings and Conclusion
Table 1. Rufinamide Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Tablets
Table 3. Major Players of Oral suspension
Table 4. Rufinamide Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Rufinamide Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Rufinamide Market Size Market Share by Type (2017-2022)
Table 7. Rufinamide Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Rufinamide Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Rufinamide Market Size Market Share by Application (2017-2022)
Table 10. Global Rufinamide Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Rufinamide Revenue Market Share by Player (2020-2022)
Table 12. Rufinamide Key Players Head office and Products Offered
Table 13. Rufinamide Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Rufinamide Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Rufinamide Market Size Market Share by Regions (2017-2022)
Table 18. Americas Rufinamide Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Rufinamide Market Size Market Share by Country (2017-2022)
Table 20. Americas Rufinamide Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Rufinamide Market Size Market Share by Type (2017-2022)
Table 22. Americas Rufinamide Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Rufinamide Market Size Market Share by Application (2017-2022)
Table 24. APAC Rufinamide Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Rufinamide Market Size Market Share by Region (2017-2022)
Table 26. APAC Rufinamide Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Rufinamide Market Size Market Share by Type (2017-2022)
Table 28. APAC Rufinamide Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Rufinamide Market Size Market Share by Application (2017-2022)
Table 30. Europe Rufinamide Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Rufinamide Market Size Market Share by Country (2017-2022)
Table 32. Europe Rufinamide Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Rufinamide Market Size Market Share by Type (2017-2022)
Table 34. Europe Rufinamide Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Rufinamide Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Rufinamide Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Rufinamide Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Rufinamide Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Rufinamide Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Rufinamide Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Rufinamide Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Rufinamide
Table 43. Key Market Challenges & Risks of Rufinamide
Table 44. Key Industry Trends of Rufinamide
Table 45. Global Rufinamide Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Rufinamide Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Rufinamide Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Rufinamide Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Rufinamide Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Rufinamide Market Size Market Share Forecast by Application (2023-2028)
Table 51. Eisai Details, Company Type, Rufinamide Area Served and Its Competitors
Table 52. Eisai Rufinamide Product Offered
Table 53. Eisai Rufinamide Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Eisai Main Business
Table 55. Eisai Latest Developments
Table 56. Glenmark Pharms Details, Company Type, Rufinamide Area Served and Its Competitors
Table 57. Glenmark Pharms Rufinamide Product Offered
Table 58. Glenmark Pharms Main Business
Table 59. Glenmark Pharms Rufinamide Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Glenmark Pharms Latest Developments
Table 61. Mylan Details, Company Type, Rufinamide Area Served and Its Competitors
Table 62. Mylan Rufinamide Product Offered
Table 63. Mylan Main Business
Table 64. Mylan Rufinamide Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Mylan Latest Developments
Table 66. West-ward Pharms Details, Company Type, Rufinamide Area Served and Its Competitors
Table 67. West-ward Pharms Rufinamide Product Offered
Table 68. West-ward Pharms Main Business
Table 69. West-ward Pharms Rufinamide Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. West-ward Pharms Latest Developments
List of Figures
Figure 1. Rufinamide Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Rufinamide Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Rufinamide Market Size Market Share by Type in 2021
Figure 7. Rufinamide in Adults
Figure 8. Global Rufinamide Market: Adults (2017-2022) & ($ Millions)
Figure 9. Rufinamide in Pediatric patients
Figure 10. Global Rufinamide Market: Pediatric patients (2017-2022) & ($ Millions)
Figure 11. Global Rufinamide Market Size Market Share by Application in 2021
Figure 12. Global Rufinamide Revenue Market Share by Player in 2021
Figure 13. Global Rufinamide Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Rufinamide Market Size 2017-2022 ($ Millions)
Figure 15. APAC Rufinamide Market Size 2017-2022 ($ Millions)
Figure 16. Europe Rufinamide Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Rufinamide Market Size 2017-2022 ($ Millions)
Figure 18. Americas Rufinamide Value Market Share by Country in 2021
Figure 19. Americas Rufinamide Consumption Market Share by Type in 2021
Figure 20. Americas Rufinamide Market Size Market Share by Application in 2021
Figure 21. United States Rufinamide Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Rufinamide Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Rufinamide Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Rufinamide Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Rufinamide Market Size Market Share by Region in 2021
Figure 26. APAC Rufinamide Market Size Market Share by Application in 2021
Figure 27. China Rufinamide Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Rufinamide Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Rufinamide Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Rufinamide Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Rufinamide Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Rufinamide Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Rufinamide Market Size Market Share by Country in 2021
Figure 34. Europe Rufinamide Market Size Market Share by Type in 2021
Figure 35. Europe Rufinamide Market Size Market Share by Application in 2021
Figure 36. Germany Rufinamide Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Rufinamide Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Rufinamide Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Rufinamide Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Rufinamide Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Rufinamide Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Rufinamide Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Rufinamide Market Size Market Share by Application in 2021
Figure 44. Egypt Rufinamide Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Rufinamide Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Rufinamide Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Rufinamide Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Rufinamide Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Rufinamide Market Size 2023-2028 ($ Millions)
Figure 50. APAC Rufinamide Market Size 2023-2028 ($ Millions)
Figure 51. Europe Rufinamide Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Rufinamide Market Size 2023-2028 ($ Millions)
Figure 53. United States Rufinamide Market Size 2023-2028 ($ Millions)
Figure 54. Canada Rufinamide Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Rufinamide Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Rufinamide Market Size 2023-2028 ($ Millions)
Figure 57. China Rufinamide Market Size 2023-2028 ($ Millions)
Figure 58. Japan Rufinamide Market Size 2023-2028 ($ Millions)
Figure 59. Korea Rufinamide Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Rufinamide Market Size 2023-2028 ($ Millions)
Figure 61. India Rufinamide Market Size 2023-2028 ($ Millions)
Figure 62. Australia Rufinamide Market Size 2023-2028 ($ Millions)
Figure 63. Germany Rufinamide Market Size 2023-2028 ($ Millions)
Figure 64. France Rufinamide Market Size 2023-2028 ($ Millions)
Figure 65. UK Rufinamide Market Size 2023-2028 ($ Millions)
Figure 66. Italy Rufinamide Market Size 2023-2028 ($ Millions)
Figure 67. Russia Rufinamide Market Size 2023-2028 ($ Millions)
Figure 68. Spain Rufinamide Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Rufinamide Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Rufinamide Market Size 2023-2028 ($ Millions)
Figure 71. Israel Rufinamide Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Rufinamide Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Rufinamide Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
